Table 1. Phenotypic Analysis of T... | American Society of Hematology

Table 1.

Phenotypic Analysis of T Lymphocytes From BMT Patients During the Follow-up Study

		Donors	Recipients (d after BMT)
		Donors	45 to 90	180 to 365	≥730
	CD4⁺ (counts/μL)	942 ± 279	325 ± 281	509 ± 274	642 ± 324
		(n = 10)	(n = 26)	(n = 10)	(n = 8)
	CD8^high+ (counts/μL)	456 ± 142	730 ± 505	895 ± 499	656 ± 372
		(n = 10)	(n = 26)	(n = 10)	(n = 8)
	CD4/CD8ratio	2	0.44	0.56	0.98
		(n = 10)	(n = 26)	(n = 10)	(n = 8)
	% CD45RO⁺	51 ± 16	80 ± 16	73 ± 17	61 ± 17
		(n = 17)	(n = 18)	(n = 10)	(n = 5)
CD4⁺	% HLA-DR⁺	3 ± 3	25 ± 14	20 ± 16	3 ± 2
		(n = 6)	(n = 14)	(n = 8)	(n = 5)
	% CD57⁺	6 ± 4	38 ± 24	14 ± 1	18 ± 13
		(n = 7)	(n = 12)	(n = 5)	(n = 5)
	% CD45RO⁺	33 ± 11	55 ± 19	58 ± 18	35 ± 9
		(n = 17)	(n = 18)	(n = 10)	(n = 5)
CD8^+high	% HLA-DR⁺	4 ± 1	18 ± 8	15 ± 12	4 ± 5
		(n = 10)	(n = 14)	(n = 8)	(n = 5)
	% CD57⁺	22 ± 8	65 ± 16	61 ± 20	51 ± 12
		(n = 7)	(n = 12)	(n = 5)	(n = 5)

		Donors	Recipients (d after BMT)
		Donors	45 to 90	180 to 365	≥730
	CD4⁺ (counts/μL)	942 ± 279	325 ± 281	509 ± 274	642 ± 324
		(n = 10)	(n = 26)	(n = 10)	(n = 8)
	CD8^high+ (counts/μL)	456 ± 142	730 ± 505	895 ± 499	656 ± 372
		(n = 10)	(n = 26)	(n = 10)	(n = 8)
	CD4/CD8ratio	2	0.44	0.56	0.98
		(n = 10)	(n = 26)	(n = 10)	(n = 8)
	% CD45RO⁺	51 ± 16	80 ± 16	73 ± 17	61 ± 17
		(n = 17)	(n = 18)	(n = 10)	(n = 5)
CD4⁺	% HLA-DR⁺	3 ± 3	25 ± 14	20 ± 16	3 ± 2
		(n = 6)	(n = 14)	(n = 8)	(n = 5)
	% CD57⁺	6 ± 4	38 ± 24	14 ± 1	18 ± 13
		(n = 7)	(n = 12)	(n = 5)	(n = 5)
	% CD45RO⁺	33 ± 11	55 ± 19	58 ± 18	35 ± 9
		(n = 17)	(n = 18)	(n = 10)	(n = 5)
CD8^+high	% HLA-DR⁺	4 ± 1	18 ± 8	15 ± 12	4 ± 5
		(n = 10)	(n = 14)	(n = 8)	(n = 5)
	% CD57⁺	22 ± 8	65 ± 16	61 ± 20	51 ± 12
		(n = 7)	(n = 12)	(n = 5)	(n = 5)